{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:58:22Z","timestamp":1787648302936,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00292-020-00808-6","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T09:03:01Z","timestamp":1596618181000},"page":"488-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cholangiokarzinome \u2013 \u00dcbersicht zur aktuellen anatomischen, histomorphologischen und morphomolekularen Klassifikation","Cholangiocarcinoma\u2014diagnosis, classification, and molecular alterations"],"prefix":"10.1007","volume":"41","author":[{"given":"Benjamin","family":"Goeppert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"issue":"Suppl 1","key":"808_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/liv.14100","volume":"39","author":"J Adeva","year":"2019","unstructured":"Adeva\u00a0J, Sangro\u00a0B, Salati\u00a0M et\u00a0al (2019) Medical treatment for cholangiocarcinoma. Liver Int 39(Suppl 1):123\u2013142","journal-title":"Liver Int"},{"key":"808_CR2","volume-title":"Armed Forces Institute of Pathology","author":"J Albores-Saavedra","year":"2000","unstructured":"Albores-Saavedra\u00a0J, Henson\u00a0DE, Klimstra\u00a0DS (2000) Armed Forces Institute of Pathology (AFIP) Atlas; tumors of the gallbladder, extrahepatic bile ducts, and ampulla of vater"},{"key":"808_CR3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","volume":"142","author":"JB Andersen","year":"2012","unstructured":"Andersen\u00a0JB, Spee\u00a0B, Blechacz\u00a0BR et\u00a0al (2012) Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology 142:1021\u20131031","journal-title":"Gastroenterology"},{"key":"808_CR4","volume-title":"WHO classification of tumours, digestive system tumours","author":"MJ Arends","year":"2019","unstructured":"Arends\u00a0MJ, Fukayama\u00a0M, Klimstra\u00a0DS et\u00a0al (2019) WHO classification of tumours, digestive system tumours, 5.\u00a0Aufl.","edition":"5"},{"key":"808_CR5","first-page":"261","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales\u00a0JM, Cardinale\u00a0V, Carpino\u00a0G et al (2016) Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of Cholangiocarcinoma (ENS-CCA). Nature reviews. Gastroenterol Hepatol 13:261\u2013280","journal-title":"Gastroenterol Hepatol"},{"key":"808_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","volume":"17","author":"DR Borger","year":"2012","unstructured":"Borger\u00a0DR, Tanabe\u00a0KK, Fan\u00a0KC et al (2012) Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 17:72\u201379","journal-title":"Oncologist"},{"key":"808_CR7","volume-title":"WHO classification of tumours of the digestive system","author":"FT Bosman","year":"2010","unstructured":"Bosman\u00a0FT, Carneiro\u00a0F, Hruban\u00a0RH et\u00a0al (2010) WHO classification of tumours of the digestive system. International Agency for Research on Cancer (IARC), Lyon, France"},{"key":"808_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater\u00a0J, Galle\u00a0PR, Khan\u00a0SA et\u00a0al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J\u00a0Hepatol 60:1268\u20131289","journal-title":"J Hepatol"},{"key":"808_CR9","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/hep.25705","volume":"56","author":"V Cardinale","year":"2012","unstructured":"Cardinale\u00a0V, Carpino\u00a0G, Reid\u00a0LM et\u00a0al (2012) Cholangiocarcinoma: a\u00a0cancer in search of the right classification. Hepatology 56:1585\u20131586 (author reply 1586)","journal-title":"Hepatology"},{"key":"808_CR10","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1002\/hep.25587","volume":"55","author":"V Cardinale","year":"2012","unstructured":"Cardinale\u00a0V, Wang\u00a0Y, Carpino\u00a0G et al (2012) Mucin-producing cholangiocarcinoma might derive from biliary tree stem\/progenitor cells located in peribiliary glands. Hepatology 55:2041\u20132042","journal-title":"Hepatology"},{"key":"808_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","volume":"32","author":"J Chaisaingmongkol","year":"2017","unstructured":"Chaisaingmongkol\u00a0J, Budhu\u00a0A, Dang\u00a0H et\u00a0al (2017) Common molecular subtypes among asian hepatocellular carcinoma and cholangiocarcinoma. Cancer Cell 32:57\u201370 e53","journal-title":"Cancer Cell"},{"key":"808_CR12","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/ng.2806","volume":"45","author":"W Chan-On","year":"2013","unstructured":"Chan-On\u00a0W, Nairismagi\u00a0ML, Ong\u00a0CK et al (2013) Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet 45:1474\u20131478","journal-title":"Nat Genet"},{"key":"808_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon\u00a0A, Laetsch\u00a0TW, Kummar\u00a0S et al (2018) Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N\u00a0Engl J Med 378:731\u2013739","journal-title":"N Engl J Med"},{"key":"808_CR14","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge\u00a0SB, Byrd\u00a0DR (2010) AJCC cancer staging manual, 7.\u00a0Aufl.","edition":"7"},{"key":"808_CR15","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1172\/JCI63212","volume":"122","author":"B Fan","year":"2012","unstructured":"Fan\u00a0B, Malato\u00a0Y, Calvisi\u00a0DF et\u00a0al (2012) Cholangiocarcinomas can originate from hepatocytes in mice. J\u00a0Clin Invest 122:2911\u20132915","journal-title":"J Clin Invest"},{"key":"808_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31110","author":"B Goeppert","year":"2020","unstructured":"Goeppert\u00a0B, Folseraas\u00a0T, Roessler\u00a0S et\u00a0al (2020) Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities. Hepatology. https:\/\/doi.org\/10.1002\/hep.31110","journal-title":"Hepatology"},{"key":"808_CR17","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/modpathol.2013.206","volume":"27","author":"B Goeppert","year":"2014","unstructured":"Goeppert\u00a0B, Frauenschuh\u00a0L, Renner\u00a0M et al (2014) BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma. Mod Pathol 27:1028\u20131034","journal-title":"Mod Pathol"},{"key":"808_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/hep.26721","volume":"59","author":"B Goeppert","year":"2014","unstructured":"Goeppert\u00a0B, Konermann\u00a0C, Schmidt\u00a0CR et\u00a0al (2014) Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway. Hepatology 59:544\u2013554","journal-title":"Hepatology"},{"key":"808_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41416-018-0199-2","volume":"120","author":"B Goeppert","year":"2019","unstructured":"Goeppert\u00a0B, Roessler\u00a0S, Renner\u00a0M et al (2019) Mismatch repair deficiency is a\u00a0rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma. Br J Cancer 120:109\u2013114","journal-title":"Br J Cancer"},{"key":"808_CR20","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/hep.30493","volume":"69","author":"B Goeppert","year":"2019","unstructured":"Goeppert\u00a0B, Toth\u00a0R, Singer\u00a0S et\u00a0al (2019) Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma. Hepatology 69:2091\u20132106","journal-title":"Hepatology"},{"key":"808_CR21","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ng.2813","volume":"45","author":"Y Jiao","year":"2013","unstructured":"Jiao\u00a0Y, Pawlik\u00a0TM, Anders\u00a0RA et\u00a0al (2013) Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 45:1470\u20131473","journal-title":"Nat Genet"},{"key":"808_CR22","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","volume":"7","author":"A Jusakul","year":"2017","unstructured":"Jusakul\u00a0A, Cutcutache\u00a0I, Yong\u00a0CH et al (2017) Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma. Cancer Discov 7:1116\u20131135","journal-title":"Cancer Discov"},{"issue":"Suppl 1","key":"808_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/liv.14093","volume":"39","author":"T Kendall","year":"2019","unstructured":"Kendall\u00a0T, Verheij\u00a0J, Gaudio\u00a0E et\u00a0al (2019) Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int 39(Suppl 1):7\u201318","journal-title":"Liver Int"},{"key":"808_CR24","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","volume":"24","author":"MA Lowery","year":"2018","unstructured":"Lowery\u00a0MA, Ptashkin\u00a0R, Jordan\u00a0E et\u00a0al (2018) Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention. Clin Cancer Res 24:4154\u20134161","journal-title":"Clin Cancer Res"},{"key":"808_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura\u00a0H, Arai\u00a0Y, Totoki\u00a0Y et\u00a0al (2015) Genomic spectra of biliary tract cancer. Nat Genet 47:1003\u20131010","journal-title":"Nat Genet"},{"key":"808_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jhep.2014.09.007","volume":"62","author":"C Raggi","year":"2015","unstructured":"Raggi\u00a0C, Invernizzi\u00a0P, Andersen\u00a0JB (2015) Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts. J\u00a0Hepatol 62:198\u2013207","journal-title":"J Hepatol"},{"key":"808_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"S Rizvi","year":"2013","unstructured":"Rizvi\u00a0S, Gores\u00a0GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145:1215\u20131229","journal-title":"Gastroenterology"},{"key":"808_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/modpathol.2013.112","volume":"27","author":"AM Schlitter","year":"2014","unstructured":"Schlitter\u00a0AM, Born\u00a0D, Bettstetter\u00a0M et\u00a0al (2014) Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways. Mod Pathol 27:73\u201386","journal-title":"Mod Pathol"},{"key":"808_CR29","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/modpathol.2015.61","volume":"28","author":"AM Schlitter","year":"2015","unstructured":"Schlitter\u00a0AM, Jang\u00a0KT, Kloppel\u00a0G et\u00a0al (2015) Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases. Mod Pathol 28:1249\u20131264","journal-title":"Mod Pathol"},{"key":"808_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-2004-828889","volume":"24","author":"Y Shaib","year":"2004","unstructured":"Shaib\u00a0Y, El-Serag\u00a0HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115\u2013125","journal-title":"Semin Liver Dis"},{"key":"808_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","volume":"128","author":"YH Shaib","year":"2005","unstructured":"Shaib\u00a0YH, El-Serag\u00a0HB, Davila\u00a0JA et al (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a\u00a0case-control study. Gastroenterology 128:620\u2013626","journal-title":"Gastroenterology"},{"key":"808_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","volume":"144","author":"D Sia","year":"2013","unstructured":"Sia\u00a0D, Hoshida\u00a0Y, Villanueva\u00a0A et\u00a0al (2013) Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 144:829\u2013840","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"808_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00292-011-1513-4","volume":"32","author":"B Sipos","year":"2011","unstructured":"Sipos\u00a0B, Henopp\u00a0T (2011) Precursor lesions of pancreatobiliary cancer. Pathologe 32(Suppl 2):224\u2013231","journal-title":"Pathologe"},{"key":"808_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.24351","volume":"54","author":"GL Tyson","year":"2011","unstructured":"Tyson\u00a0GL, El-Serag\u00a0HB (2011) Risk factors for cholangiocarcinoma. Hepatology 54:173\u2013184","journal-title":"Hepatology"},{"key":"808_CR35","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s10620-014-3276-2","volume":"59","author":"GL Tyson","year":"2014","unstructured":"Tyson\u00a0GL, Ilyas\u00a0JA, Duan\u00a0Z et\u00a0al (2014) Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification. Dig Dis Sci 59:3103\u20133110","journal-title":"Dig Dis Sci"},{"key":"808_CR36","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/liv.13954","volume":"39","author":"D Walter","year":"2019","unstructured":"Walter\u00a0D, Ferstl\u00a0P, Waidmann\u00a0O et\u00a0al (2019) Cholangiocarcinoma in Germany: epidemiologic trends and impact of misclassification. Liver Int 39:316\u2013323","journal-title":"Liver Int"},{"key":"808_CR37","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","volume":"68","author":"CP Wardell","year":"2018","unstructured":"Wardell\u00a0CP, Fujita\u00a0M, Yamada\u00a0T et\u00a0al (2018) Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J\u00a0Hepatol 68:959\u2013969","journal-title":"J Hepatol"},{"key":"808_CR38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/modpathol.3800788","volume":"20","author":"Y Zen","year":"2007","unstructured":"Zen\u00a0Y, Adsay\u00a0NV, Bardadin\u00a0K et\u00a0al (2007) Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 20:701\u2013709","journal-title":"Mod Pathol"},{"key":"808_CR39","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.21387","volume":"44","author":"Y Zen","year":"2006","unstructured":"Zen\u00a0Y, Fujii\u00a0T, Itatsu\u00a0K et\u00a0al (2006) Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 44:1333\u20131343","journal-title":"Hepatology"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-020-00808-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T23:32:13Z","timestamp":1628119933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-020-00808-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s00292-020-00808-6","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"5 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Goeppert gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}